PlainPharmaWatch

CMS Open Payments · Program Year 2024

Delphinus Medical Technologies, Inc.

Delphinus Medical Technologies, Inc. reported $435,024.84 across General Payments, Research, and Ownership to 135 physicians and teaching hospitals across 135 transactions.

See the rankings → How this is sourced
$435.0K
All-tracks total
135
Transactions
135
Recipients
−$126.8K
General Payments vs PY2023

Delphinus Medical Technologies, Inc. reported $435,024.84 across all CMS Open Payments tracks (General + Research + Ownership) to 135 physicians and teaching hospitals in Program Year 2024 - ranking #799 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $435,024.84, averaging $3.2K per recipient.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the publisher.

CMS Sunshine Act warrant

Manufacturer delphinus-medical-technologies-inc Delphinus Medical Technologies, Inc.

$435.0K · #799/1,925 · 0.0% industry · PY2024

  • TOT $435.0K
  • RANK #799
  • SHARE 0.0%
  • TXN 135
  • RCP 135
  • CAT 2
  • GEN $435.0K
  • ΔGEN −$126.8K
  • TOP1 33.6%
  • PY 2024

Volume peers

Nearest volume peer: NeuroLogica Corporation, a subsidiary of Samsung Electronics Co., Ltd. ($434.8K)

PhotoniCare Inc$437.5KPadagis US LLC$436.5KDelphinus Medical Technologi…$435.0KNeuroLogica Corporation, a s…$434.8KSpectrum Pharmaceuticals Inc.$434.4K
All-tracks payment totals near Delphinus Medical Technologies, Inc. (CMS Open Payments PY2024)

Delphinus Medical Technologies, Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →

Release-over-release change

General Payments changed from PY2023 to PY2024

Delphinus Medical Technologies, Inc.'s CMS-reported General Payments decreased by $126.8K (−22.6%) from PY2023 to PY2024.

How this year-over-year comparison is scoped

The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.

CMS source labels for this exact identifier: PY2023: DELPHINUS MEDICAL TECHNOLOGIES, INC.PY2024: Delphinus Medical Technologies, Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.

Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.

General Payments: PY2023 vs PY2024

Annual CMS-reported totals for this company, not an all-category Open Payments total

PY2023$561.9KPY2024$435.0K
PY2023
$561,854.69
PY2024
$435,024.84

What the Data Shows for Delphinus Medical Technologies, Inc.

In Program Year 2024, Delphinus Medical Technologies, Inc. reported $435,024.84 in payments to 135 physicians and teaching hospitals across 135 individual transactions, an average of $3.2K per transaction and $3.2K per recipient. That total places Delphinus Medical Technologies, Inc. at rank #799 out of 1,925 companies in the CMS Open Payments database, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.

Of the 2 general-payment categories charted below, "Consulting Fee" is the largest at $430.8K across 63 transactions, 99.0% of this company's General Payments (see our methodology for how research and ownership payments are reported separately).

General Payment Breakdown by Type

Across 2 types of general payments, Delphinus Medical Technologies, Inc.'s largest category was "Consulting Fee" at $430.8K - 99.0% of General Payments.

How Delphinus Medical Technologies, Inc. divides its payments

Top payment categories by total reported dollar volume

1. Consulting Fee$430.8K2. Food and Beverage$4.2K
Payment Type Amount Transactions
Consulting Fee $430.8K 63
Food and Beverage $4.2K 72

Recipient Concentration in General Payments

The five largest recipient relationships account for $430,551.56 (99.0%) of $435,024.84 in this company's General Payments records across 26 recipients.

General Payments scope note

Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Delphinus Medical Technologies, Inc.

The five named recipients with the highest reported General Payments from this company

Peter Littrup$146.0KRachel Brem$144.0KMary Yamashita$125.9KVashita Dhir$14.1KArthy Saravanan$550.44
  1. 1

    Peter Littrup

    $146,000.16 across 24 reported transactions

  2. 2

    Rachel Brem

    $144,000.00 across 24 reported transactions

  3. 3

    Mary Yamashita

    $125,899.98 across 16 reported transactions

  4. 4

    Vashita Dhir

    $14,100.98 across 11 reported transactions

  5. 5

    Arthy Saravanan

    $550.44 across 7 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Similarly Concentrated Companies

Companies whose General Payments are spread across recipients about as (un)evenly as Delphinus Medical Technologies, Inc.'s, measured by the same HHI concentration index above, not by payment size.

What HHI 2,500 means here

2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Delphinus Medical Technologies, Inc..

Cook Research Incorporated

HHI 3073

Perfuze Limited

HHI 3056

Medicaroid, Inc.

HHI 3056

Republic Spine

HHI 3085

Companies with Similar Payment Volumes

Open a profile or compare a similar company's CMS-reported payment pattern with Delphinus Medical Technologies, Inc..

Showing 6 of 1,924 companies with CMS-reported payment data.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download Delphinus Medical Technologies, Inc.'s data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.